Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS mo

SOLV Energy NASDAQ: MWH reported record first-half results for 2026, citing increased new-constructi

SOLV Energy, Inc. (MWH) Q2 2026 Earnings Call Transcript

SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MW

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Bank of America Corp DE boosted its holdings in Solventum Corporation (NYSE: SOLV) by 0.6% during th

Solventum NYSE: SOLV reported second-quarter results that exceeded its internal expectations, suppor

SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.5%, prompting higher 2026

UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Buy and raises the price target

Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises t

Wedbush analyst Michael Piccolo maintains Solventum (NYSE:SOLV) with a Outperform and raises the

Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the pr

Stifel analyst Rick Wise maintains Solventum (NYSE:SOLV) with a Buy and raises the price target f

BTIG analyst Ryan Zimmerman maintains Solventum (NYSE:SOLV) with a Buy and raises the price targe

Solventum Corporation (SOLV) Q2 2026 Earnings Call Transcript

Solventum (SOLV) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Es

The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter

Solventum , one of the largest providers of hospital consumables and sterilization devices, said on

Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Informatio

Solventum (NYSE:SOLV) reported quarterly earnings of $2.55 per share which beat the analyst consensu

Reported sales increased 2.2%; organic sales increased 9.5% Announces intent to separate its Health

Strengthens the focus of Solventum as a dedicated MedTech company and advances its three-phase trans

McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs,

SOLV's Q2 results are likely to benefit from segment strength, Acera gains and cost savings, offset

Nelson Peltz's Trian Fund Management has emerged as the largest institutional shareholder of Solvent

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus

Arrowstreet Capital Limited Partnership cut its position in Solventum Corporation (NYSE: SOLV) by 8.

BMO Capital initiates coverage on Solventum (NYSE:SOLV) with a Market Perform rating and announces

Wedbush analyst Michael Piccolo initiates coverage on Solventum (NYSE:SOLV) with a Outperform rat

UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Neutral and lowers the price ta

Stifel analyst Rick Wise maintains Solventum (NYSE:SOLV) with a Buy and lowers the price target f

Wells Fargo analyst Larry Biegelsen maintains Solventum (NYSE:SOLV) with a Equal-Weight and lower

Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the pr

Full-Year 2026 GuidanceSolventum is affirming its full year 2026 guidance:Organic sales growth of +2

Solventum (NYSE:SOLV) reported quarterly earnings of $1.48 per share which beat the analyst consensu

Solventum shares are rebounding Thursday after activist investor Trian Fund criticized post‑spin per

Trian believes Solventum would be a considerably more valuable company today if the Board and manage

Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and lowers the pr

Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and lowers t

Wall Street analysts change outlook on top names. Check analyst ratings page for upgrades, downgrade

Rothschild & Co analyst Jackson Philips initiates coverage on Solventum (NYSE:SOLV) with a Se

Wells Fargo analyst Vik Chopra maintains Solventum (NYSE:SOLV) with a Equal-Weight and lowers the

Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the pr

Solventum (NYSE:SOLV) reported quarterly earnings of $1.57 per share which beat the analyst consensu